Longitudinal and Individual Symptom Analyses of Momelotinib and Ruxolitinib-Treated Myelofibrosis Patients from SIMPLIFY-1
Mesa R., Hudgens S., Floden L., Palmer J., Gupta V., McLornan D., McMullin MF., Kiladjian J-J., Foltz L., Platzbecker U., Fox LM., Mead A., Ross D., Oh S., Perkins A., Leahy MF., Deheshi S., Donahue R., Klencke B., Verstovsek S.